1Dawe RS, Wainwright N J, Cameron H, et al. Narrowband (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment. Br J Dermatol 1998,138 : 833 - 839.
4Gottlieb A, Krueger JG, Bright R, et al. Effects of administration of a single dose of humanized monoclonal antibody to CDlla on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000; 42: 428-435.
5Gottlieb A, Miller B, Chaudhari U, et al.Clinical and histologic effect of subcutaneously administered anti - CDlla in patients with psoriasis. J Invest Dermatol 2000;114:840.
6Gottlieb A, Abdulghani A, Totoritis R, et al.Results of a single- dose, dose - escalating trial of anti- B7 monoclonal antibody (IDEC-114) in patients with psoriasis. J Invest Dennatol 2000; 114:546.
7Ravindra A, Nitika V. Biotherapy: a novel approach in the treatment of psoriasis. Drugs of the Fut:Lre 2002;27:1071 - 1077.
8Krueger JG, Waiters B, Miyazawa M, et al.Successful in vivo blockade of CD25 on T cells by administration of humanized anti - Tac antibody to patients with psoriasis. J Am Acad Dermatol 2000;43:448-458.
9Asadullah K, Friedrich M, Hanneken S, et al. Effects of systemic interleukin - 10 therapy on psoriatic skin lision: histologic, immunohistologic and molecular biology findings. J Invest Dermatol 2001 ; 116:721 - 727.
10Duan H, Koga T, Kohda F, et al. Interleukin- 8 positive neutrophils in psoriasis. J Deamatol Sci 2001;26:119.
